COVID-19 Vaccine, Inactivated, Omicron Strain(Sinovac Biotech)(COVID-19 Vaccine, Inactivated, Omicron Strain(Sinovac Biotech))

概要

基本信息

药物类型

预防性疫苗

别名

COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain(Sinovac Biotech)

靶点

SARS-CoV-2 antigen

作用方式

抑制剂

作用机制

新冠病毒抗原抑制剂

治疗领域-

在研适应症-

非在研适应症-

原研机构

科兴控股生物技术有限公司

在研机构

科兴控股生物技术有限公司

非在研机构-

最高研发阶段临床2期

首次获批日期-

最高研发阶段(中国)临床2期

特殊审评-

登录后查看时间轴

关联

2

项与 COVID-19 Vaccine, Inactivated, Omicron Strain(Sinovac Biotech) 相关的临床试验

ChiCTR2200062420

/ Suspended临床3期IIT

To evaluate the safety and immunogenicity of Omicron strain inactivated COVID-19 vaccine (Vero cells) in population aged 18 years and above who have not been vaccinated against COVID-19

开始日期2022-07-25

申办/合作机构-

NCT05411471

/ Completed临床2期

A Phase IIb, Randomized, Open-labeled Trial to Evaluate the Immunogenicity and Safety of One or Two Doses of Booster Vaccine With the COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain in Adults in Hong Kong

This is a randomized, open-labeled, Phase IIb clinical trial.The purpose of this study is to evaluate the immunogenicity and safety of the booster vaccine of using one or two doses of COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain in Adults above 18 Years Old Who Have Completed Two or Three Doses of mRNA Vaccine or CoronaVac®.

开始日期2022-06-08

申办/合作机构

科兴控股生物技术有限公司

100 项与 COVID-19 Vaccine, Inactivated, Omicron Strain(Sinovac Biotech) 相关的临床结果

登录后查看更多信息

100 项与 COVID-19 Vaccine, Inactivated, Omicron Strain(Sinovac Biotech) 相关的转化医学

登录后查看更多信息

100 项与 COVID-19 Vaccine, Inactivated, Omicron Strain(Sinovac Biotech) 相关的专利（医药）

登录后查看更多信息

100 项与 COVID-19 Vaccine, Inactivated, Omicron Strain(Sinovac Biotech) 相关的药物交易

登录后查看更多信息